These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31676269)

  • 1. A Wish List for Drug Development in Pediatrics.
    Meyers R
    J Pharm Sci; 2020 Feb; 109(2):939-943. PubMed ID: 31676269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
    Giacoia GP; Taylor-Zapata P; Mattison D
    Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal and pediatric oral drug delivery: Hopes and hurdles.
    Mfoafo KA; Omidian M; Bertol CD; Omidi Y; Omidian H
    Int J Pharm; 2021 Mar; 597():120296. PubMed ID: 33524524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric drug formulations: challenges and potential solutions.
    Nahata MC
    Ann Pharmacother; 1999 Feb; 33(2):247-9. PubMed ID: 10084423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric formulations: international issues and potential solutions.
    Knoppert DC
    Paediatr Drugs; 2009; 11(1):55-6. PubMed ID: 19127956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extemporaneous drug formulations.
    Nahata MC; Allen LV
    Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extemporaneous dosage preparations for pediatrics.
    Rappaport PL
    Can J Hosp Pharm; 1983; 36(3):66-70, 74. PubMed ID: 10262678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor preservation efficacy versus quality and safety of pediatric extemporaneous liquids.
    Ghulam A; Keen K; Tuleu C; Wong IC; Long PF
    Ann Pharmacother; 2007 May; 41(5):857-60. PubMed ID: 17440007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drugs for children--when temporary solutions become routine].
    Kalikstad B; Westergren T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):930-2. PubMed ID: 16554887
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges in pediatric drug use: A pharmacist point of view.
    Balan S; Hassali MA; Mak VSL
    Res Social Adm Pharm; 2017; 13(3):653-655. PubMed ID: 27493130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of practices for suspended oral drugs by tablet crushing in pediatric units.
    Nguyen D; Secretan PH; Auvity S; Vidal F; Postaire M; Cisternino S; Schlatter J
    Eur J Pharm Biopharm; 2020 Dec; 157():175-182. PubMed ID: 33222769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Reviews on Pediatric Dosage Form Developments and Medical Devices.
    Kaur G; Nagpal D; Nagpal K
    Crit Rev Ther Drug Carrier Syst; 2020; 37(6):553-590. PubMed ID: 33426833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Educational paper: formulation-related issues in pediatric clinical pharmacology.
    Tuleu C; Breitkreutz J
    Eur J Pediatr; 2013 Jun; 172(6):717-20. PubMed ID: 23111761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues impacting therapeutic outcomes in pediatric patients: an overview.
    Kalra A; Goindi S
    Curr Pediatr Rev; 2014; 10(3):184-93. PubMed ID: 25088338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Problems posed by the adjusting of a dosage form of a drug for children].
    Bernheim C
    Therapie; 1989; 44(2):145-50. PubMed ID: 2756521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric and geriatric drug delivery.
    Breitkreutz J; Boos J
    Expert Opin Drug Deliv; 2007 Jan; 4(1):37-45. PubMed ID: 17184161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do Japanese children take their medicines, and what are pharmacists and paediatricians doing about it?
    Nakamura H; Ishikawa Y
    Int J Pharm; 2014 Aug; 469(2):249-50. PubMed ID: 24704105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basics of compounding foam dosage forms.
    Allen LV
    Int J Pharm Compd; 2013; 17(4):312-22. PubMed ID: 24261147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.